Skip to search formSkip to main contentSkip to account menu

arbaclofen placarbil

Known as: 4-chloro-beta-((((2-methyl-1-(2-methyl-1-oxopropoxy)propoxy)carbonyl)amino)methyl)benzenepropanoic acid 
National Institutes of Health

Related topics

Related topics

5 relations

Broader (3)

BaclofenGABA-B Receptor AgonistsMuscle Relaxants, Central

Narrower (1)

XP19986
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
An Ongoing Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects with Spasticity Due to Multiple Sclerosis (P03.267)
OBJECTIVE: This ongoing, Phase 3 trial is evaluating the efficacy and safety of 3 doses of arbaclofen placarbil (AP), compared… 
2012
2012
1153 A Dose-Response Efficacy and Safety Study of Arbaclofen Placarbil as Adjunctive Therapy in GERD Patients Who Incompletely Responded to PPI Therapy
2009
2009
Arbaclofen Placarbil Monotherapy Improves Sleep Quality in Patients Who Have Previously Responded to a PPI: 14
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)